FDA Accepts Supplement for ADRENALIN (Epinephrine) NDA204640
The FDA has accepted a supplemental application for ADRENALIN, which contains epinephrine as the active ingredient.
Therapeutic Area
Therapeutic area intelligence for Adrenal Insufficiency with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.